This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Masso-Welch, P. A. Articles by Ip, M. M. Search for Related Content PubMed PubMed Citation Articles by Masso-Welch, P. A. Articles by Ip, M. M.

Inhibition of Angiogenesis by the Cancer Chemopreventive Agent Conjugated Linoleic Acid¹

Departments of Pharmacology and Therapeutics [P. A. M-W., D. Z., M. M. V., S. S., R. A. R., M. M. I.] and Cancer Prevention [C. I.], Roswell Park Cancer Institute, Buffalo, New York 14263

Dietary conjugated linoleic acid (CLA) has been shown previously to inhibit rat mammary carcinogenesis. In addition to direct effects on mammary epithelial cells,including decreased proliferation and induction of apoptosis, CLA may exert its effects indirectly by inhibiting the differentiation of mammary stromal cells to an endothelial cell type. Specifically, CLA was found to decrease the ability of mammary stromal cells to form complex anastomosing microcapillary networks in vitro on Engelbreth-Holm-Swarm-derived reconstituted basement membrane. This suggested that CLA might inhibit angiogenesis in vivo. To test this possibility, CD2/F₁ mice were placed on synthetic diets containing 0, 1, or 2% CLA for 6 weeks, before angiogenic challenge by s.c. injection with an angiogenic gel substrate (Matrigel pellet assay). After 7 days, the pellets from animals fed the control diet were infiltrated by abundant branching networks of blood vessels with patent lumen-containing RBCs. In contrast, pellets from the CLA-fed animals contained fewer infiltrating cells, which formed limited branching cellular networks, the majority of which had collapsed lumen and no RBCs. Both levels of dietary CLA showed similar effects, with the number of RBC-containing vessels per 20x field decreased to a third of that seen in control. Dietary CLA decreased serum levels of vascular endothelial growth factor (VEGF) and whole mammary gland levels of VEGF and its receptor Flk-1. Both cis-9, trans-11 and trans-10, cis-12 CLA isomers were effective in inhibiting angiogenesis in vitro in a dose-dependent fashion. The ability of CLA to inhibit angiogenesis may contribute to its efficacy as a chemopreventive agent.

This article has been cited by other articles:

				T. Tsuzuki and Y. Kawakami Tumor angiogenesis suppression by {alpha}-eleostearic acid, a linolenic acid isomer with a conjugated triene system, via peroxisome proliferator-activated receptor {gamma} Carcinogenesis, April 1, 2008; 29(4): 797 - 806. [Abstract] [Full Text] [PDF]

				K. Nakagawa, A. Shibata, S. Yamashita, T. Tsuzuki, J. Kariya, S. Oikawa, and T. Miyazawa In Vivo Angiogenesis Is Suppressed by Unsaturated Vitamin E, Tocotrienol J. Nutr., August 1, 2007; 137(8): 1938 - 1943. [Abstract] [Full Text] [PDF]

				M. M. Ip, S. O. McGee, P. A. Masso-Welch, C. Ip, X. Meng, L. Ou, and S. F. Shoemaker The t10,c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epithelium Carcinogenesis, June 1, 2007; 28(6): 1269 - 1276. [Abstract] [Full Text] [PDF]

				L. M. Rodriguez-Alcala and J. Fontecha Hot Topic: Fatty Acid and Conjugated Linoleic Acid (CLA) Isomer Composition of Commercial CLA-Fortified Dairy Products: Evaluation After Processing and Storage J Dairy Sci, May 1, 2007; 90(5): 2083 - 2090. [Abstract] [Full Text] [PDF]

				J. S. Russell, S. O. McGee, M. M. Ip, D. Kuhlmann, and P. A. Masso-Welch Conjugated Linoleic Acid Induces Mast Cell Recruitment during Mouse Mammary Gland Stromal Remodeling J. Nutr., May 1, 2007; 137(5): 1200 - 1207. [Abstract] [Full Text] [PDF]

				T. Tsuzuki, A. Shibata, Y. Kawakami, K. Nakagawa, and T. Miyazawa Conjugated Eicosapentaenoic Acid Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Suppressing the Migration of Human Umbilical Vein Endothelial Cells J. Nutr., March 1, 2007; 137(3): 641 - 646. [Abstract] [Full Text] [PDF]

				T. Tsuzuki, Y. Tokuyama, M. Igarashi, K. Nakagawa, Y. Ohsaki, M. Komai, and T. Miyazawa {alpha}-Eleostearic Acid (9Z11E13E-18:3) Is Quickly Converted to Conjugated Linoleic Acid (9Z11E-18:2) in Rats J. Nutr., October 1, 2004; 134(10): 2634 - 2639. [Abstract] [Full Text] [PDF]

				T. Tsuzuki, Y. Tokuyama, M. Igarashi, and T. Miyazawa Tumor growth suppression by {alpha}-eleostearic acid, a linolenic acid isomer with a conjugated triene system, via lipid peroxidation Carcinogenesis, August 1, 2004; 25(8): 1417 - 1425. [Abstract] [Full Text] [PDF]

				H. J. Thompson, J. N. McGinley, P. Wolfe, N. S. Spoelstra, and K. K. Knott Targeting Angiogenesis for Mammary Cancer Prevention: Factors to Consider in Experimental Design and Analysis Cancer Epidemiol. Biomarkers Prev., July 1, 2004; 13(7): 1173 - 1184. [Abstract] [Full Text] [PDF]

				M. W Pariza Perspective on the safety and effectiveness of conjugated linoleic acid Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1132S - 1136S. [Abstract] [Full Text] [PDF]

				C. J Field and P. D Schley Evidence for potential mechanisms for the effect of conjugated linoleic acid on tumor metabolism and immune function: lessons from n-3 fatty acids Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1190S - 1198S. [Abstract] [Full Text] [PDF]

				P. A. Masso-Welch, D. Zangani, C. Ip, M. M. Vaughan, S. F. Shoemaker, S. O. McGee, and M. M. Ip Isomers of Conjugated Linoleic Acid Differ in Their Effects on Angiogenesis and Survival of Mouse Mammary Adipose Vasculature J. Nutr., February 1, 2004; 134(2): 299 - 307. [Abstract] [Full Text] [PDF]

				B. A. Corl, D. M. Barbano, D. E. Bauman, and C. Ip cis-9, trans-11 CLA Derived Endogenously from trans-11 18:1 Reduces Cancer Risk in Rats J. Nutr., September 1, 2003; 133(9): 2893 - 2900. [Abstract] [Full Text] [PDF]